//
Steven Knapper
Michael Dennis
Mark W Drummond
Robert K. Hills
Richard James Dillon
Christopher Pocock
Dominic J. Culligan
Paresh Vyas
Daniel Wiseman
Joanna Zabkiewicz
Marie Hodges
Catherine Cargo
Jan Taylor
Laura Upton
Melissa Wright
David Bowen
Department of Haematology, Cardiff University, School of Medicine, Cardiff, United Kingdom
Department of Haematology and Transplant, The Christie, Manchester, United Kingdom
Beatson West of Scotland Cancer Centre and University of Glasgow, Glasgow, United Kingdom
Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom
Kings College London, London, United Kingdom
East Kent Hospitals, Canterbury, United Kingdom
Aberdeen Royal Infirmary, Aberdeen, United Kingdom
IGF Group, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom
Institute of Cancer & Genetics, Cardiff University, Cardiff, Wales, United Kingdom
St James's University Hospital, Haematological Malignancy Diagnostic Service (HMDS), Leeds, United Kingdom
Centre for Trials Research, College of Biomedical & Life Sciences, Cardiff University, Cardiff, United Kingdom
Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom
United Kingdom
N/A
Oncology (ONC)
Chronic myelomonocytic leukemia
Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon
Hydroxycarbamide
Tefinostat
N/A
Single Arm
Multinational
II
N/A
N/A
N/A